Experiences and Management Practices of Individuals Living with Sickle Cell Anemia in Nigeria

Abstract

Background: Sickle cell anemia (SCA) remains a major public health concern in Nigeria, where it significantly affects the physical, emotional, and social well-being of affected individuals. Despite advancements in medical care, many patients continue to face challenges related to disease management and societal perceptions.

Purpose: This study aimed to explore the experiences and management practices of individuals living with SCA in Nigeria.

Methods: A descriptive cross-sectional study was conducted among individuals living with sickle cell anemia in Nigeria using a structured online questionnaire distributed through WhatsApp support groups. Ethical approval was obtained from the Federal Medical Centre, Abeokuta, Nigeria. A voluntary participant recruitment approach was employed, and data collected included socio-demographic characteristics, disease experiences, pain triggers, and management practices. Data were analyzed using descriptive statistics in SPSS and Microsoft Excel.

Result: Out of 307 individuals contacted, 66 respondents completed the survey (21.5% response rate). Most respondents were female (69.6%), aged 31-40 years (51.5%), and had the HbSS genotype (72.7%). Frequent pain crises were reported by 42.4% of participants, while 69.7% stated that sickle cell disease had negatively affected their life pursuits. Societal discrimination was experienced by 68.1% of respondents. Malaria was the most commonly reported trigger of pain crises (34%), followed by stress and extremely cold weather. Medication was the most common management strategy (47.0%), while hospital visitation was the preferred approach during crises (59%).

Conclusion: The study highlights the complex realities of living with SCA in Nigeria, characterized by frequent clinical complications, diverse management practices, and substantial psychosocial burdens.

  • Page Number : 57-66

  • Published Date : 2026-08-14

  • Keywords
    Sickle cell anemia, HbSS genotype, Stigma, Frequent clinical complications

  • DOI Number
    10.15415/jmrh.2026.122005

  • Authors
    Abidemi Esther Ojo, Regina Oghenevwede Golagha, Olugbenga Anthony Ojo, Adejare Rasaq Oloyede, Oluwabusola Oluwayemi Adegbesan, and Eniola Akindele

References

  • Adegoke, S., & Abioye-Kuteyi, E. (2012). Psychosocial burden of sickle cell disease on the family, Nigeria. African Journal of Primary Health Care and Family, 4(1), 1–6. https://doi.org/10.4102/phcfm.v4i1.380
  • Adeloye, D., Auta, A., Ale, B. M., Thompson, J. Y., Rudan, I., & Global Health Epidemiology Research Group (GHERG). (2026). Prevalence estimates of sickle cell disease among children and adolescents in sub-Saharan Africa: A systematic review and modelling analysis. The Lancet. Child and Adolescent Health, 10(6), 438–447. https://doi.org/10.1016/S2352-4642(26)00048-9
  • Adewoyin, A. S. (2015). Management of sickle cell disease: A review for physician education in Nigeria (Sub-Saharan Africa). Anemia, 2015(1), 791498. https://doi.org/10.1155/2015/791498
  • Adigwe, O. P., Onavbavba, G., & Onoja, S. O. (2023). Impact of sickle cell disease on affected individuals in Nigeria: A critical review. International Journal of General Medicine, 16, 3503–3515. https://doi.org/10.2147/IJGM.S410015
  • Akodu, S., Diaku-Akinwumi, I., & Njokanma, O. (2013). Age at diagnosis of sickle cell anemia in Lagos, Nigeria. Mediterranean Journal of Hematology and Infectious Diseases, 5(1), e2013001. https://doi.org/10.4084/mjhid.2013.001
  • Ambe, J. P., Mava, Y., & Chirdan, O. (2001). Clinical profile of sickle cell anemia in Nigerian children and effects on schooling. African Journal of Medicine and Medical Sciences, 30(3), 195–199. https://pubmed.ncbi.nlm.nih.gov/23208475/
  • Ameh, S. J., Tarfa, F. D., & Ebeshi, B. U. (2012). Traditional herbal management of sickle cell anemia: Lessons from Nigeria. Anemia, 2012(1), 607436. https://doi.org/10.1155/2012/607436
  • Anie, K. A. (2005). Psychological complications in sickle cell disease. British Journal of Haematology, 129(6), 723–729. https://doi.org/10.1111/j.1365-2141.2005.05500.x
  • Anie, K. A., & Green, J. (2015). Psychological therapies for sickle cell disease and pain. The Cochrane Database of Systematic Reviews, 2015(5), CD001916. https://doi.org/10.1002/14651858.CD001916.pub3
  • Ballas, S. K., Lieff, S., Benjamin, L. J., Dampier, C. D., Heeney, M. M., Hoppe, C., Johnson, C. S., Rogers, Z. R., Smith-Whitley, K., Wang, W. C., Telen, M. J., & Investigators, Comprehensive Sickle Cell Centers. (2010). Definitions of the phenotypic manifestations of sickle cell disease. American Journal of Hematology, 85(1), 6–13. https://doi.org/10.1002/ajh.21550
  • Berhe, K. T., Gesesew, H. A., & Ward, P. R. (2024). Traditional healing practices, factors influencing to access the practices and its complementary effect on mental health in sub-Saharan Africa: A systematic review. BMJ Open, 14(9), e083004. https://doi.org/10.1136/bmjopen-2023-083004
  • Brown, B. J., Okereke, J. O., Lagunju, I. A., Orimadegun, A. E., Ohaeri, J. U., & Akinyinka, O. O. (2010). Burden of health-care of carers of children with sickle cell disease in Nigeria. Health & Social Care in the Community, 18(3), 289–295. https://doi.org/10.1111/j.1365-2524.2009.00903.x
  • Bulgin, D., Tanabe, P., & Jenerette, C. (2018). Stigma of sickle cell disease: A systematic review. Issues in Mental Health Nursing, 39(8), 675–686. https://doi.org/10.1080/01612840.2018.1443530
  • Bunn, H. F. (1997). Pathogenesis and treatment of sickle cell disease. The New England Journal of Medicine, 337(11), 762–769. https://doi.org/10.1056/NEJM199709113371107
  • Canals-Gispert, L., Cañas-Martínez, A., Huesa, G., Suárez-Calvet Alomà, M., Milà-Alomà, M., Arenaza-Urquijo, E., Cirillo, D., Dimech, A. S., Iulita, M. F., Martinkova, J. N., Tartaglia, M. C., Quevenco, F. C., Chadha, A. S., Sánchez-Benavides, G., Minguillón, C., Ferretti, M. T., Fauria, K., Brugulat-Serrat, A., & ALFA Study. (2024). Impact of gender on the willingness to participate in clinical trials and undergo related procedures in individuals from an Alzheimer's prevention research cohort. Alzheimer's Research & Therapy, 16(1), 263. https://doi.org/10.1186/s13195-024-01626-1
  • Diaku-Akinwumi, I. N., Abubakar, S. B., Adegoke, S. A., Adeleke, S., Adewoye, O., Adeyemo, T., Akinbami, A., Akinola, N. O., Akinsulie, A., Akinyoola, A., Aneke, J., Awwalu, S., Babadoko, A., Brown, B., Ejike, O., Emodi, I., George, I., Girei, A., Hassan, A., Kangiwa, G. U., Lawal, O. A., Mabogunje, C., Madu, A. J., Mustapha, A., Ndakotsu, M., Nnodu, O. E., Nwaneri, D., Odey, F. F., Ohiaeri, C., Olaosebikan, R., Olatunya, O. S., Oniyangi, O., Opara, H., Ugwu, N. I., Musa, A. U., Abdullahi, S., Usman, A., Utuk, E., Jibir, B. W., & Adekile, A. D. (2016). Blood transfusion services for patients with sickle cell disease in Nigeria. International Health, 8(5), 330–335. https://doi.org/10.1093/inthealth/ihw014
  • Elendu, C., Amaechi, D. C., Alakwe-Ojimba, C. E., Elendu, T. C., Elendu, R. C., Ayabazu, C. P., Aina, T. O., Aborisade, O., & Adenikinju, J. S. (2023). Understanding sickle cell disease: Causes, symptoms, and treatment options. Medicine, 102(38), e35237. https://doi.org/10.1097/MD.0000000000035237
  • Essien, E. A., Winter-Eteng, B. F., Onukogu, C. U., Nkangha, D. D., & Daniel, F. M. (2023). Psychosocial challenges of persons with sickle cell anemia: A narrative review. Medicine, 102(47), e36147. https://doi.org/10.1097/MD.0000000000036147
  • Gazta, P., Gautam, J., Thakor, M., Bhardwaj, P., & Mohanty, S. S. (2026). Role of the primary healthcare providers in sickle cell disease management: A scoping review. Journal of Community Genetics, 17(2), 35. https://doi.org/10.1007/s12687-026-00867-x
  • Hassell, K. L. (2010). Population estimates of sickle cell disease in the U.S. American Journal of Preventive Medicine, 38(4), S512–S521. https://doi.org/10.1016/j.amepre.2009.12.022
  • Juburi, G. A., Okoye, O., Majeed, A., Knight, Y., Green, S. A., Banarsee, R., ... & Phekoo, K. J. (2012). Views of patients about sickle cell disease management in primary care: A questionnaire-based pilot study. JRSM Short Reports, 3(11), 1–5. https://doi.org/10.1258/shorts.2012.011173
  • Kilonzi, M., Mwakawanga, D. L., Felician, F. F., Mlyuka, H. J., Chirande, L., Myemba, D. T., Sambayi, G., Mutagonda, R. F., Mikomangwa, W. P., Ndunguru, J., Jonathan, A., Ruggajo, P., Minja, I. K., Balandya, E., Makani, J., & Sirili, N. (2022). The effects of sickle cell disease on the quality of life: A focus on the untold experiences of parents in Tanzania. International Journal of Environmental Research and Public Health, 19(11), 6871. https://doi.org/10.3390/ijerph19116871
  • Mangla, A., Agarwal, N., & Maruvada, S. (2023). Sickle cell anemia. In StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. Available from: https://www.ncbi.nlm.nih.gov/books/NBK482164/
  • McGann, P. T., Nero, A. C., & Ware, R. E. (2013). Current management of sickle cell anemia. Cold Spring Harbor Perspectives in Medicine, 3(8), a011817. https://doi.org/10.1101/cshperspect.a011817
  • Meraya, A. M., Banji, O. J. F., Menachery, S. J., Malhan, H. M. A., Halawi, H. A. A., Moraya, D., Hakami, H. A., Kubayni, A. M., Alfaifi, Y. Y., Ghareeb, H. I., Rasayn, M. A. A., & Alfaifi, R. A. (2026). Clinical, humanistic, and economic burden of sickle cell disease in The Jazan Region, Saudi Arabia. PLOS ONE, 21(5), e0348759. https://doi.org/10.1371/journal.pone.0348759
  • Mutombo, P. N., Kasilo, O. M. J., James, P. B., Wardle, J., Kunle, O., Katerere, D., Wambebe, C., Matsabisa, M. G., Rahmatullah, M., Mukankubito, I., Sheridan, R., Sanogo, R., Nissapatorn, V., Sivakorn, C., Tripathy, S., Goyal, R., & Dhobi, M. (2023). Experiences and challenges of African traditional medicine: Lessons from COVID-19 pandemic. BMJ Global Health, 8(8), e010813. https://doi.org/10.1136/bmjgh-2022-010813
  • Nelson, M., Noisette, L., Pugh, N., Gordeuk, V., Hsu, L. L., Wun, T., Shah, N., Glassberg, J., Kutlar, A., Hankins, J. S., King, A. A., Brambilla, D., & Kanter, J. (2024). The clinical spectrum of HbSC sickle cell disease not a benign condition. British Journal of Haematology, 205(2), 653–663. https://doi.org/10.1111/bjh.19523
  • Ohene-Frempong, K., Weiner, S. J., Sleeper, L. A., Miller, S. T., Embury, S., Moohr, J. W., Wethers, D. L., Pegelow, C. H., & Gill, F. M. (1998). Cerebrovascular accidents in sickle cell disease: Rates and risk factors. Blood, 91(1), 288–294. https:// https://pubmed.ncbi.nlm.nih.gov/9414296/
  • Olatunya, O. S., Babatola, A. O., Adeniyi, A. T., Lawal, O. A., Daramola, A. O., Agbesanwa, T. A., Olumuyiwa Ojo, T., Ajayi, P. O., Ibijola, A. A., Komolafe, A. K., & Adekile, A. (2021). Determinants of care-seeking practices for children with sickle cell disease in Ekiti, Southwest Nigeria. Journal of Blood Medicine, 12, 123–132. https://doi.org/10.2147/JBM.S294952
  • Serjeant, G. R. (2013). The natural history of sickle cell disease. Cold Spring Harbor Perspectives in Medicine, 3(10), a011783. https://doi.org/10.1101/cshperspect.a011783
  • Shapiro, B. S., Dinges, D. F., Orne, E. C., Bauer, N., Reilly, L. B., Whitehouse, W. G., Ohene-Frempong, K., & Orne, M. T. (1995). Home management of sickle cell-related pain in children and adolescents: Natural history and impact on school attendance. Pain, 61(1), 139–144. https://doi.org/10.1016/0304-3959(94)00164-A
  • Tewari, S., Brousse, V., Piel, F., & Menzel, S. (2015). Environmental determinants of severity in sickle cell disease. Haematologica, 100(9), 1108–1116. https://doi.org/10.3324/haematol.2014.120030
  • Thomas, V. J., & Taylor, L. M. (2002). The psychosocial experience of people with sickle cell disease and its impact on quality of life: Qualitative findings from focus groups. British Journal of Health Psychology, 7(3), 345–363. https://doi.org/10.1348/135910702760213724
  • Verdugo-Castro, S., Sánchez-Gómez, M. C., & García-Holgado, A. (2023). Factors associated with the gender gap in the STEM sector: Comparison of theoretical and empirical concept maps and qualitative SWOT analysis. Heliyon, 9(6), e17499. https://doi.org/10.1016/j.heliyon.2023.e17499
  • Yusuf, H. R., Atrash, H. K., Grosse, S. D., Parker, C. S., & Grant, A. M. (2010). Emergency department visits made by patients with sickle cell disease: A descriptive study, 1999–2007. American Journal of Preventive Medicine, 38(4 Suppl), S536–S541. https://doi.org/10.1016/j.amepre.2010.01.001